Egea Biosciences, Inc.

1652 Via Cancion
San Marcos, CA 92069
5 Employees

SBIR Award Summary

Total Number of Awards 7
Total Value of Awards $2.15MM
First Award Date 12/16/99
Most Recent Award Date 02/01/02

Key Personnel

Last Name Name Awards Contact
Evans Dr. Glen A. Evans 7 Message

7 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-00-18
Budget: 02/01/02 - 01/31/03

Biological Nanostructures Nanotechnology is a critical field for the future of biomedicine and involves the creation of functional material, devices and systems through the control of matter at the scale of 1 to 100 nanometers. Physical techniques, such as atomic force and scanning tunneling microscopy, optical traps and tweezers, nanoscale carb...

Phase 2 SBIR

Agency: Defense Advanced Research Projects Agency
Topic: SB001-011
Budget: 10/15/01 - 01/16/04

Biological warfare (BW) and bioterrorism are significant and increasing global threats. Genetic engineering made possible by the Human Genome Project may allow the development of novel BW agents and escalation of the BW threat. Major problems in biological weapons defense are the identification of the biological agent, determining the pathogen...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-00-18
Budget: 02/01/01 - 01/31/02

Biological Nanostructures Nanotechnology is a critical field for the future of biomedicine and involves the creation of functional material, devices and systems through the control of matter at the scale of 1 to 100 nanometers. Physical techniques, such as atomic force and scanning tunneling microscopy, optical traps and tweezers, nanoscale carb...

Phase 2 SBIR

Agency: Army
Topic: A99-065
Budget: 01/02/01 - 05/31/03

Recombinant expression of human proteins is a potentially valuable method for large scale production of hemostatic materials. However, manufacturing-scale production using traditional recombinant DNA techniques is problematic due to the low yield of active protein and complex purification. We propose to utilize a novel technique to produce hemo...

Phase 1 SBIR

Agency: Defense Advanced Research Projects Agency
Topic: SB001-011
Budget: 04/19/00 - 12/28/00

Biological warfare (BW) and bioterrorism are significant and escalating global threats. Genetic and genomic engineering made possible by the Human Genome Project may allow the customization of BW agents and escalation of the BW threat. Major problems in biological weapons defense are the identification of the biological agent, determining the p...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 04/01/00 - 09/30/00

The Human Genome Sequencing Project is generating a vast amount of raw sequence information. However, a limitation in the analysis of new human proteins is the difficulty of converting digital sequence information into "wet" material in the laboratory. Conventional recombinant cloning is expensive, time consuming and limited in scope. We propose...

Phase 1 SBIR

Agency: Army
Topic: A99-065
Budget: 12/16/99 - 12/15/00

Recombinant expression of human proteins is a potentially valuable method for large scale production of hemostatic materials. However, manufacturing-scale production using traditional recombinant DNA techniques is problematic due to the low yield of active protein and complex purification. We propose to utilize a novel technique to produce hemo...